Positron Emission Tomography (PET) Market Size, Share, Growth, Demand And Report 2024-2032

0
41

Summary: 

  • The global positron emission tomography market size reached USD 1,196.1 Million in 2023.
  • The market is expected to reach USD 1,934.9 Million by 2032, exhibiting a growth rate (CAGR) of 5.33% during 2024-2032.
  • North America leads the market, accounting for the largest positron emission tomography market share.
  • Based on the product type, the market has been segmented into full-ring pet scanners and partial-ring pet scanners.
  • On the basis of the detector type, the market has been segregated into bismuth germanium oxide (BGO), lutetium oxyorthosilicate (LSO), lutetium fine silicate (LFS), lutetium yttrium orthosilicate (LYO), and gadolinium oxyorthosilicate (GSO).
  • Oncology remains a dominant segment in the market due to the high cancer prevalence and the essential role PET scans play in early detection and treatment plannin.
  • Based on the end user, the market has been divided into hospitals and clinics, diagnostic centers, and others.
  • The rising use of PET scans in oncology is a primary driver of the positron emission tomography market.
  • The positron emission tomography market growth and forecast highlight a significant rise due to progress in radiotracer development.

Industry Trends and Drivers: 

  • Increasing Use of PET Scans in Oncology:

The industry is experiencing several positron emission tomography market trends such as its expanding use in oncology. PET scans are highly effective in detecting and monitoring various types of cancers by providing detailed images of cellular activity. This capability supports early diagnosis, accurate staging, and improved treatment planning, which are critical for successful patient outcomes. Advances in radiopharmaceuticals have further enhanced the precision of PET imaging, allowing for more targeted imaging of specific cancer types. The high prevalence of cancer globally has led to increased demand for PET scans, as healthcare providers prioritize early detection and personalized treatment strategies. This trend is expected to continue as innovations in PET technology and radiotracers make the technique more accessible and effective for oncology applications and increase the positron emission tomography demand.

  • Integration of PET with Other Imaging Modalities:

Another significant trend in the PET market is the integration of PET with other imaging modalities, such as computed tomography (CT) and magnetic resonance imaging (MRI). Hybrid imaging systems like PET/CT and PET/MRI combine the functional imaging of PET with the detailed anatomical information provided by CT or MRI, leading to more comprehensive diagnostic capabilities. This integration improves the accuracy of diagnoses, assists in precise treatment planning, and enhances the ability to track treatment responses. The adoption of these multimodal systems is growing as healthcare providers seek more efficient and reliable diagnostic solutions. This trend is fueled by the expansion of positron emission tomography market share.

  • Advancements in Radiotracer Development:

The development of new radiotracers is shaping the future of the PET market by expanding the range of conditions that can be effectively imaged. While fluorodeoxyglucose (FDG) remains the most commonly used radiotracer for PET scans, new compounds are being developed to target specific types of tissues and diseases beyond oncology, such as Alzheimer’s disease and cardiovascular conditions. These advancements are opening up new applications for PET imaging in neurology and cardiology, contributing to the market’s growth. The innovation in radiotracer development also supports more precise and personalized diagnostic approaches, helping clinicians tailor treatment plans based on detailed imaging results. This trend is expected to drive the adoption of PET technology across a broader range of medical fields, expanding the positron emission tomography market size.

Request Sample For PDF Report: https://www.imarcgroup.com/positron-emission-tomography-market/requestsample

Market Report Segmentation:

Breakup by Product Type:

  • Full Ring PET Scanners
  • Partial Ring PET Scanners

Based on the product type, the market has been segmented into full-ring pet scanners and partial-ring pet scanners.

Breakup by Detector Type:

  • Bismuth Germanium Oxide (BGO)
  • Lutetium Oxyorthosilicate (LSO)
  • Lutetium Fine Silicate (LFS)
  • Lutetium Yttrium Orthosilicate (LYO)
  • Gadolinium Oxyorthosilicate (GSO)

On the basis of the detector type, the market has been segregated into bismuth germanium oxide (BGO), lutetium oxyorthosilicate (LSO), lutetium fine silicate (LFS), lutetium yttrium orthosilicate (LYO), and gadolinium oxyorthosilicate (GSO).

Breakup by Application:

  • Cardiology
  • Neurology
  • Oncology
  • Others

Oncology represents the majority of shares due to the high prevalence of cancer and the critical role of PET scans in early detection and treatment planning.

Breakup by End-User:

  • Hospitals and Clinics
  • Diagnostic Centers
  • Others

Based on the end user, the market has been divided into hospitals and clinics, diagnostic centers, and others.

Regional Insights:

  • North America (United States, Canada)
  • Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, Others)
  • Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
  • Latin America (Brazil, Mexico, Others)
  • Middle East and Africa

North America holds the leading position owing to a large market for positron emission tomography driven by its advanced healthcare infrastructure, high adoption of cutting-edge imaging technologies, and significant investment in medical research.

Top Positron Emission Tomography Market Leaders:

  • Agfa Healthcare (Dedalus Group)
  • GE Healthcare
  • Koninklijke Philips NV
  • Neusoft Medical Systems
  • Positron Corporation
  • Oncovision (Bruker)
  • Mediso Medical Imaging Systems Ltd.
  • Siemens Healthineers AG
  • Segami Corporation
  • Hitachi Ltd.

Note: If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.

About Us:

IMARC Group is a global management consulting firm that helps the world’s most ambitious changemakers to create a lasting impact. The company provide a comprehensive suite of market entry and expansion services. IMARC offerings include thorough market assessment, feasibility studies, company incorporation assistance, factory setup support, regulatory approvals and licensing navigation, branding, marketing and sales strategies, competitive landscape and benchmarking analyses, pricing and cost research, and procurement research.